The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke

Stroke

Volumn 43, Issue 5, 2012, Pages 1315-1322

  Saposnik, Gustavo ^a,b,c,e,f   Fang, Jiming ^c   Kapral, Moira K ^c,d,e   Tu, Jack V ^c,e   Mamdani, Muhammad ^b,c,e,f   Austin, Peter ^c,e   Johnston, S Claiborne ^f  

^a Stroke Outcomes Research Unit   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral infarct; Outcomes; Prognosis; Stroke care; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; HOSPITAL DISCHARGE; HUMAN; ISCORE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84860223906     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.646265     Document Type: Article

References (26)

1. Nichols-Larsen DS, Clark PC, Zeringue A, Greenspan A, Blanton S. Factors influencing stroke survivors' quality of life during subacute recovery. Stroke. 2005;36:1480-1484. (Pubitemid 40967516)
2. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: A systematic review. Lancet Neurol. 2009;8:741-754.
3. Adams HP, Jr., del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115:e478-534.
4. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282. (Pubitemid 46138121)
5. Konig IR, Ziegler A, Bluhmki E, Hacke W, Bath PM, Sacco RL, et al. Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke. 2008;39: 1821-1826.
6. Weimar C, Konig IR, Kraywinkel K, Ziegler A, Diener HC. Age and national institutes of health stroke scale score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke. 2004;35:158-162. (Pubitemid 38057612)
7. Solberg OG, Dahl M, Mowinckel P, Stavem K. Derivation and validation of a simple risk score for predicting 1-year mortality in stroke. J Neurol. 2007;254:1376-1383. (Pubitemid 350119680)
8. German Stroke Study Collaboration. Predicting outcome after acute ischemic stroke: an external validation of prognostic models. Neurology. 2004;62:581-585.
9. Saposnik G, Young B, Silver B, Di Legge S, Webster F, Beletsky V, et al. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. JAMA. 2004;292:1839-1844. (Pubitemid 40169294)
10. Saposnik G, Kapral MK, Liu Y, Hall R, O'Donnell M, Raptis S, et al. iScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation. 2011;123:739-749.
11. Saposnik G, Kapral MK, Liu Y, Raptis S, Tu JV, Mamdani M, et al. The iScore predicts functional outcomes early after hospitalization for an acute ischemic stroke. Stroke. 2011;42:3421-3428.
12. Kapral MK, Silver FL, Richards JA, Lindsay MP, Fang J, Shi S, et al. Registry of the Canadian stroke network. Progress report 2001-2005. ICES. Toronto. 2005.
13. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007;26: 734-753. (Pubitemid 46206593)
14. Austin PC. Comparing paired vs non-paired statistical methods of analyses when making inferences about absolute risk reductions in propensity-score matched samples. Stat Med. 2011;30:1292-1301.
15. Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using manyto-one matching on the propensity score. Am J Epidemiol. 2011;172: 1092-1097.
16. Agresti A, Min Y. Effects and non-effects of paired identical observations in comparing proportions with binary matched-pairs data. Stat Med. 2004;23:65-75. (Pubitemid 38072107)
17. Blacker DJ, Phatouros CC. Beyond IV thrombolysis for acute ischaemic stroke. Intern Med J. 2011;41:645.
18. Mitchell J, Lang E. Evidence-based emergency medicine. Update: effect of thrombolysis in acute ischemic stroke. Ann Emerg Med. 2011;57: e16-e17.
19. Merino JG, Silver B, Wong E, Demaerschalk B, Tamayo A, Hachinski V. Physician knowledge of the benefits, risks, and contraindications of tissue plasminogen activator for acute ischemic stroke. Stroke. 2001;32: 2208-2209. (Pubitemid 32868129)
20. Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: A systematic review. JAMA. 2005;293:1223-1238. (Pubitemid 40327908)
21. Cucchiara B, Tanne D, Levine SR, Demchuk AM, Kasner S. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2008;17: 331-333.
22. Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the multicenter rtPA stroke survey. Circulation. 2002;105:1679-1685. (Pubitemid 34298612)
23. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke. 2006;37: 2957-2962. (Pubitemid 44900816)
24. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
25. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
26. Mishra NK, Ahmed N, Andersen G, Egido JA, Lindsberg PJ, Ringleb PA, et al. Thrombolysis in very elderly people: controlled comparison of sits international stroke thrombolysis registry and virtual international stroke trials archive. BMJ. 2011;341:c6046.